Skip to main content

Alpine Immune Sciences, Inc.

ALPNDelisted May 20, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001626199

Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Alpine Immune Sciences, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of ALPN: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6177+16
Shares41.4M43.7M+2.33M (+5.6%)
Value$319.4M$449.3M+$129.8M (+40.6%)

New holders (18)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to ALPN in Q2 2023
InstitutionSharesValue% of portfolio
Vivo Capital, LLC914,913$9.41M1.13%
Tri Locum Partners LP331,992$3.41M1.27%
Woodline Partners LP237,564$2.44M0.03%
Millennium Management LLC116,175$1.19M0.00%
Soleus Capital Management, L.P.88,073$905.4K0.10%
ExodusPoint Capital Management, LP62,839$646.0K0.01%
Two Sigma Investments, LP58,028$596.5K0.00%
Citadel Advisors LLC53,723$552.3K0.00%
Westwood Holdings Group Inc.43,799$450.0K0.00%
Trexquant Investment LP42,773$439.7K0.01%
Mirae Asset Global Investments Co., Ltd.17,081$175.6K0.00%
Alliancebernstein L.P.15,820$162.6K0.00%
Moore Capital Management, LP13,844$142.3K0.00%
Manufacturers Life Insurance Company, The13,483$138.6K0.00%
Voya Investment Management LLC13,136$135.0K0.00%
Schonfeld Strategic Advisors LLC12,900$132.6K0.00%
Panagora Asset Management Inc12,394$127.4K0.00%
Dorsey Wright & Associates2,351$24.2K0.01%

Sold out (2)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of ALPN in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
BVF Inc858,339$6.63M
SG Americas Securities, LLC11,927$92.0K